Recent insider trading activity from Alspaugh Jonathan, including buys and sells reported to the SEC.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 22, 2023 | Spyre Therapeutics, Inc. | $SYRE | Alspaugh Jonathan | President and CFO | A | Employee Stock Option (right to buy) | 19787969 | $0.00 | 19,787,969.0000 | 0 | 9999.99% | 0.00% |
| Feb. 23, 2023 | Spyre Therapeutics, Inc. | $SYRE | Alspaugh Jonathan | Chief Financial Officer | A | Employee Stock Option (right to buy) | 640000 | $0.00 | 640,000.0000 | 0 | 9999.99% | 0.00% |